132 related articles for article (PubMed ID: 34706517)
1. Molecular profile of parathyroid tissues and tumours: a heterogeneous landscape.
Uljanovs R; Strumfa I; Bahs G; Vidusa L; Merkurjeva K; Franckevica I; Strumfs B
Pol J Pathol; 2021; 72(2):99-116. PubMed ID: 34706517
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.
Ozolins A; Narbuts Z; Vanags A; Simtniece Z; Visnevska Z; Akca A; Wirowski D; Gardovskis J; Strumfa I; Goretzki PE
Langenbecks Arch Surg; 2016 Nov; 401(7):943-951. PubMed ID: 26658808
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
Erickson LA; Jin L; Wollan P; Thompson GB; van Heerden JA; Lloyd RV
Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of cell cycle regulators, Fhit protein and apoptotic cells in parathyroid lesions.
Thomopoulou GE; Tseleni-Balafouta S; Lazaris AC; Koutselini H; Kavantzas N; Davaris PS
Eur J Endocrinol; 2003 Jan; 148(1):81-7. PubMed ID: 12534361
[TBL] [Abstract][Full Text] [Related]
5. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
6. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
7. Defining a molecular phenotype for benign and malignant parathyroid tumors.
Fernandez-Ranvier GG; Khanafshar E; Tacha D; Wong M; Kebebew E; Duh QY; Clark OH
Cancer; 2009 Jan; 115(2):334-44. PubMed ID: 19107770
[TBL] [Abstract][Full Text] [Related]
8. Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.
Buchwald PC; Akerström G; Westin G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):389-93. PubMed ID: 15009006
[TBL] [Abstract][Full Text] [Related]
9. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues.
Naccarato AG; Marcocci C; Miccoli P; Bonadio AG; Cianferotti L; Vignali E; Cipollini G; Viacava P
J Endocrinol Invest; 1998 Mar; 21(3):136-41. PubMed ID: 9591207
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.
Stojadinovic A; Hoos A; Nissan A; Dudas ME; Cordon-Cardo C; Shaha AR; Brennan MF; Singh B; Ghossein RA
Hum Pathol; 2003 Jan; 34(1):54-64. PubMed ID: 12605367
[TBL] [Abstract][Full Text] [Related]
12. Molecular Characteristics of Large Parathyroid Adenomas.
Agarwal A; Pradhan R; Kumari N; Krishnani N; Shukla P; Gupta SK; Chand G; Mishra A; Agarwal G; Verma AK; Mishra SK
World J Surg; 2016 Mar; 40(3):607-14. PubMed ID: 26669787
[TBL] [Abstract][Full Text] [Related]
13. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma.
Kim HK; Oh YL; Kim SH; Lee DY; Kang HC; Lee JI; Jang HW; Hur KY; Kim JH; Min YK; Chung JH; Kim SW
Head Neck; 2012 Feb; 34(2):201-6. PubMed ID: 21717519
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review.
Uljanovs R; Sinkarevs S; Strumfs B; Vidusa L; Merkurjeva K; Strumfa I
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805976
[TBL] [Abstract][Full Text] [Related]
15. Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors.
Wang O; Wang CY; Shi J; Nie M; Xia WB; Li M; Jiang Y; Guan H; Meng XW; Xing XP
Chin Med J (Engl); 2012 Aug; 125(16):2895-901. PubMed ID: 22932087
[TBL] [Abstract][Full Text] [Related]
16. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
17. The role of hyperplasia in multiple parathyroid adenomas.
Larian B; Alavi S; Roesler J; Namazie A; Blackwell K; Calcaterra TC; Wang MB
Head Neck; 2001 Feb; 23(2):134-9. PubMed ID: 11303630
[TBL] [Abstract][Full Text] [Related]
18. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
19. Primary hyperparathyroidism: a current perspective.
DeLellis RA; Mazzaglia P; Mangray S
Arch Pathol Lab Med; 2008 Aug; 132(8):1251-62. PubMed ID: 18684024
[TBL] [Abstract][Full Text] [Related]
20. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
Cetani F; Ambrogini E; Viacava P; Pardi E; Fanelli G; Naccarato AG; Borsari S; Lemmi M; Berti P; Miccoli P; Pinchera A; Marcocci C
Eur J Endocrinol; 2007 May; 156(5):547-54. PubMed ID: 17468190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]